EirGenix
New Taipei City, Taiwan eirgenix.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
EirGenix is a biologics CDMO and biosimilar developer that serves biopharmaceutical clients. It operates cGMP manufacturing facilities in Xizhi, New Taipei City and Zhubei, Hsinchu County, Taiwan.
Services
Cell Line Development
Develops expression vectors and stable producer cell lines for downstream process development and manufacturing.
Cell line development
Process Development
Provides end-to-end development and analytical testing support for biopharmaceuticals from pre-clinical to commercial scale.
Analytical & Quality Control
Offers analytical services, method development, validation, and transfer to quality control for GMP production.
cGMP Manufacturing - Mammalian System
Provides contract development and manufacturing services for biologics in mammalian systems from pre-clinical to commercial scale.
cGMP Manufacturing - Microbial System
Provides contract development and manufacturing services for microbial-derived biologics from pre-clinical to commercial stages.
ADC & Bioconjugates
Develops and manufactures antibody-drug conjugates and other conjugates, including non-cytotoxic conjugates.
Commercial / Market-Available Products
Markets EG12014, a trastuzumab biosimilar sold as EIRGASUN® and HERWENDA® in different markets.
Supporting Products & Platforms
Supplies CRM197 carrier protein and HRV3C protease in GMP-grade and R&D-grade formats.
Capabilities
- Assays and studies
- ADCs
- Process development
- Antibodies
- Bioreactors
- Analytical development
- Analytical testing
9 more
- Analytical method development
- Method validation
- Quality control testing
- Method transfer
- Method qualification
- Raw material testing
- In-process testing
- Lot release testing
- Stability testing
- Scale and capacity
- Pre-clinical scale
- Pilot-scale
- Late-stage clinical scale
- Commercial scale
- 200 L-2,000 L single-use bioreactors
- 20 L-1,500 L microbial fermentation systems
- Preclinical and pilot-scale mammalian manufacturing
- Late-stage clinical and commercial-scale mammalian manufacturing
- Therapeutic areas
- Biopharmaceuticals
- Breast cancer
- Conjugate vaccines
Modalities and species
- Modalities
- Antibody
- ADC
- Recombinant protein
- Vaccine
- Biosimilar
- Plasmid DNA
- Species and models
- Mammalian cells
- Microbial systems
- Mammalian cell culture
- Microbial fermentation
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacturing facilities and services
Industries served
- Biopharmaceuticals
- Biotech
Details
- Type
- CRDMO
- Founded
- 2012
- Based in
- New Taipei City, Taiwan
- Sites
- Xizhi, New Taipei City, Taiwan
- Zhubei, Hsinchu County, Taiwan
- Serves
- Global, 15+ countries